We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The White House on Wednesday highlighted the administration’s ongoing efforts to rein in illegal fentanyl trafficking and unveiled a series of advisories to help businesses identify “red flags.” Read More
In a first for the UK’s Competition and Markets Authority (CMA), Aspen Pharma agreed to pay the National Health Service £8 million ($9.7 million) to settle anti-competition charges involving fludrocortisone acetate — an oral corticosteroid used to treat Addison’s disease and for other conditions. Read More
U.S. Sen. Gary Peters (D-Mich.) sent a letter Wednesday to acting FDA Commissioner Ned Sharpless asking what the agency is doing to curb drug shortages. Read More
Sarepta Therapeutics was “surprised” to receive a complete response letter from the FDA for its new drug application for Vydonos 53 (golodirsen) for treatment of Duchenne muscular dystrophy. Read More
Progressive groups organized a series of rallies across the country Tuesday as part of a “People Over Pharma Profits” day of action. The coalition — dubbed “Lower Drug Prices Now” — includes Public Citizen, Health Care for America Now, Families USA, and MoveOn. The group planned 51 “People Over Pharma Profits” events across 32 states. Read More